Quarterly report pursuant to Section 13 or 15(d)

Summary Significant Accounting Policies Parentheticals (Details)

v2.4.0.8
Summary Significant Accounting Policies Parentheticals (Details) (USD $)
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Summary Significant Accounting Policies Parentheticals    
Amortization of deferred financing costs related to convertible debt $ 13,015 $ 72,154
Costs of patents written off (ProAlgaZyme) 6,234  
Intellectual property 1,391,281  
Research Expenses - Salaries and equipment related expenses 30,351 102,440
Clinical Studies expenses - fees, charges and related expenses 680,825 441,490
Compensation expenses recorded 360,103 34,935
Advertising/Public Relation costs charged to operating expenses $ 27,551 $ 22,289